Health

Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer

TribeNews
By TribeNews Add a Comment
0 Min Read
Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck Cancer

MedPage Today) — CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in certain patients with locally advanced head and neck squamous cell carcinoma (HNSCC), according…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app